These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25343542

  • 1. Fluorouracil, leucovorin and irinotecan combined with intra-arterial hepatic infusion of drug-eluting beads preloaded with irinotecan in unresectable colorectal liver metastases: side effects and results of a concomitant treatment schedule. Clinical investigation.
    Kekez D, Badzek S, Prejac J, Gorsic I, Golem H, Librenjak N, Perkov D, Smiljanic R, Plestina S.
    Tumori; 2014; 100(5):499-503. PubMed ID: 25343542
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N, Akinwande O, Martin RC.
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [Abstract] [Full Text] [Related]

  • 3. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
    Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M, Padr R, Rocek M, Scupchenko A, Tatum C.
    Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
    [Abstract] [Full Text] [Related]

  • 4. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S, Artru P, Mithieux F, Marsot J, Watkin E, Pellerin O, Lledo G, Chalabreysse P, Desramé J, Taieb J.
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM.
    Cancer; 2015 Oct 15; 121(20):3649-58. PubMed ID: 26149602
    [Abstract] [Full Text] [Related]

  • 6. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.
    Scevola G, Loreni G, Rastelli M, Sposato S, Ramponi S, Miele V.
    Med Oncol; 2017 Mar 15; 34(3):37. PubMed ID: 28160267
    [Abstract] [Full Text] [Related]

  • 7. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
    Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V, Coschiera P.
    Anticancer Res; 2012 Apr 15; 32(4):1387-95. PubMed ID: 22493375
    [Abstract] [Full Text] [Related]

  • 8. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
    de Baere T, Tselikas L, Boige V, Ducreux M, Malka D, Goéré D, Benahim E, Deschamps F.
    Bull Cancer; 2017 May 15; 104(5):402-406. PubMed ID: 27993355
    [Abstract] [Full Text] [Related]

  • 9. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ, Laurence JM, Lam VW.
    J Vasc Interv Radiol; 2013 Aug 15; 24(8):1209-17. PubMed ID: 23885916
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]

  • 11. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
    Martin RC, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, Sharma V.
    J Gastrointest Surg; 2012 Aug 01; 16(8):1531-8. PubMed ID: 22528576
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
    Yamaguchi T, Matsumoto H, Yasutome M, Mori T, Takahashi K.
    Cancer Chemother Pharmacol; 2011 Mar 01; 67(3):629-35. PubMed ID: 20495917
    [Abstract] [Full Text] [Related]

  • 13. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
    Shimonov M, Hayat H, Chaitchik S, Brener J, Schachter P, Czerniak A.
    Chemotherapy; 2005 May 01; 51(2-3):111-5. PubMed ID: 15886466
    [Abstract] [Full Text] [Related]

  • 14. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003 May 01; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

  • 15. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Akinwande O, Scoggins C, Martin RC.
    Anticancer Res; 2016 Jul 01; 36(7):3413-8. PubMed ID: 27354601
    [Abstract] [Full Text] [Related]

  • 16. Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases.
    Min BS, Kim NK, Ahn JB, Roh JK, Kim KS, Choi JS, Cha SH, Kim H.
    Onkologie; 2007 Dec 01; 30(12):637-43. PubMed ID: 18063876
    [Abstract] [Full Text] [Related]

  • 17. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.
    Chin Med J (Engl); 2012 Oct 01; 125(20):3640-5. PubMed ID: 23075717
    [Abstract] [Full Text] [Related]

  • 18. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
    Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M.
    BMC Cancer; 2004 Jul 20; 4():38. PubMed ID: 15265233
    [Abstract] [Full Text] [Related]

  • 19. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
    Pernot S, Pellerin O, Artru P, Montérymard C, Smith D, Raoul JL, De La Fouchardière C, Dahan L, Guimbaud R, Sefrioui D, Jouve JL, Lepage C, Tougeron D, Taieb J, for FFCD1201-DEBIRI investigators/Collaborators.
    Br J Cancer; 2020 Aug 20; 123(4):518-524. PubMed ID: 32507854
    [Abstract] [Full Text] [Related]

  • 20. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G, Barbery K, Suthar R, Guerrero G, Arora G.
    Anticancer Res; 2013 May 20; 33(5):2077-83. PubMed ID: 23645758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.